Moz and others,
I have been a holder for many years and will continue to be. Everything I have researched and read leads me to believe that we are on a winner. My question is why have we not been offered a deal from a big pharmaceutical. Look at the deal for GLPG1972 that you discussed and they cant pass their phase two. Surely we must be an attractive proposition for someone? Why haven't we been offered a deal? If they were and they rejected it would this have to be released to the market? I just cant understand how lesser products are getting great deals yet we cant? any opinions would be greatly apricated.
YIN AND YANG Part 2, page-5
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.010(3.45%) |
Mkt cap ! $97.94M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 28.0¢ | $40.10K | 140.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 135929 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 20969 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |